Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · IEX Real-Time Price · USD
10.11
-0.41 (-3.90%)
At close: May 28, 2024, 4:00 PM
10.16
+0.05 (0.49%)
After-hours: May 28, 2024, 4:55 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $321.25 million as of May 28, 2024. Its market cap has decreased by -8.53% in one year.
Market Cap
321.25M
Enterprise Value
363.41M
1-Year Change
-8.53%
Ranking
Category
Stock Price
$10.11
Market Cap Chart
Since January 19, 2007, Zynex's market cap has increased from $7.90M to $321.25M, an increase of 3,966.42%. That is a compound annual growth rate of 23.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 24, 2024 | 334.30M | 2.23% |
May 23, 2024 | 327.00M | -1.71% |
May 22, 2024 | 332.70M | -1.04% |
May 21, 2024 | 336.20M | 0.21% |
May 20, 2024 | 335.50M | -2.95% |
May 17, 2024 | 345.70M | -1.09% |
May 16, 2024 | 349.50M | -0.09% |
May 15, 2024 | 349.80M | 1.36% |
May 14, 2024 | 345.10M | 1.68% |
May 13, 2024 | 339.40M | 1.83% |
May 10, 2024 | 333.30M | 1.43% |
May 9, 2024 | 328.60M | -3.61% |
May 8, 2024 | 340.90M | -1.93% |
May 7, 2024 | 347.60M | 1.85% |
May 6, 2024 | 341.30M | -2.35% |
May 3, 2024 | 349.50M | -4.69% |
May 2, 2024 | 366.70M | -1.95% |
May 1, 2024 | 374.00M | 7.29% |
Apr 30, 2024 | 348.60M | -5.35% |
Apr 29, 2024 | 368.30M | 2.14% |
Apr 26, 2024 | 360.60M | 2.47% |
Apr 25, 2024 | 351.90M | -2.60% |
Apr 24, 2024 | 361.30M | -0.25% |
Apr 23, 2024 | 362.20M | 1.06% |
Apr 22, 2024 | 358.40M | -2.10% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
MeiraGTx Holdings | 339.86M |
Sutro Biopharma | 338.63M |
Anavex Life Sciences | 338.57M |
Skye Bioscience | 338.50M |
Nautilus Biotechnology | 336.96M |
LifeMD | 331.55M |
Replimune Group | 320.59M |
Treace Medical Concepts | 319.96M |